LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus

BACKGROUND: Enzybiotics are promising alternatives to conventional antibiotics for drug-resistant infections. Exolysins, as a class of enzybiotics, show antibacterial effects against methicillin-resistant Staphylococcus aureus (MRSA). This study evaluated a novel exolysin containing an SH3b domain f...

Descripción completa

Detalles Bibliográficos
Autores principales: Asadi, Marzieh, Taheri-Anganeh, Mortaza, Ranjbar, Maryam, Khatami, Seyyed Hossein, Maleksabet, Amir, Mostafavi-Pour, Zohreh, Ghasemi, Younes, Keshavarzi, Abdolkhalegh, Savardashtaki, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500863/
https://www.ncbi.nlm.nih.gov/pubmed/37704938
http://dx.doi.org/10.1186/s12866-023-03002-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500863/
https://www.ncbi.nlm.nih.gov/pubmed/37704938
http://dx.doi.org/10.1186/s12866-023-03002-9

Ejemplares similares